FINWIRES · TerminalLIVE
FINWIRES

Amgen Q1 Adjusted Earnings, Revenue Rise

By

Amgen (AMGN) reported Q1 adjusted earnings late Thursday of $5.15 per diluted share, up from $4.90 a year earlier.

Analysts polled by FactSet expected $4.77.

Revenue for the three months ended March 31 was $8.62 billion, up from $8.15 billion a year earlier.

Analysts surveyed by FactSet expected $8.58 billion.

For the full-year 2026, the company now expects adjusted EPS of $21.70 to $23.10 on revenue of $37.10 billion to $38.50 billion. Analysts expect EPS of $22.33 on revenue of $37.81 billion.

Related Articles